Home/Filings/4/0001209191-22-002426
4//SEC Filing

Clements Ian 4

Accession 0001209191-22-002426

CIK 0001759425other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:52 PM ET

Size

7.2 KB

Accession

0001209191-22-002426

Insider Transaction Report

Form 4
Period: 2022-01-06
Clements Ian
SVP Finance & Communications
Transactions
  • Award

    Common Stock

    2022-01-06+10,00028,561 total
  • Award

    Stock Option (right to buy)

    2022-01-06+60,00060,000 total
    Exercise: $15.87Exp: 2032-01-05Common Stock (60,000 underlying)
Footnotes (2)
  • [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
  • [F2]1/4th of the shares vest one year after January 6, 2022 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1
  • filerCIK 0001780080

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:52 PM ET
Size
7.2 KB